ASP Isotopes Inc. (NASDAQ:ASPI) COO Sells $374,674.16 in Stock

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) COO Robert Ainscow sold 66,668 shares of the company’s stock in a transaction on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $374,674.16. Following the completion of the sale, the chief operating officer now directly owns 1,419,992 shares in the company, valued at $7,980,355.04. This trade represents a 4.48 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Robert Ainscow also recently made the following trade(s):

  • On Tuesday, April 15th, Robert Ainscow sold 66,666 shares of ASP Isotopes stock. The shares were sold at an average price of $5.75, for a total transaction of $383,329.50.

ASP Isotopes Stock Performance

Shares of ASPI opened at $5.84 on Friday. The company has a 50-day moving average of $4.74 and a two-hundred day moving average of $5.19. The stock has a market cap of $420.88 million, a P/E ratio of -9.57 and a beta of 3.44. ASP Isotopes Inc. has a 12-month low of $1.86 and a 12-month high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Charles Schwab Investment Management Inc. increased its position in ASP Isotopes by 16.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock worth $334,000 after buying an additional 17,159 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new position in ASP Isotopes in the 3rd quarter valued at about $52,000. State Street Corp lifted its holdings in ASP Isotopes by 12.8% in the 3rd quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after purchasing an additional 96,604 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of ASP Isotopes by 31.7% during the 3rd quarter. Jane Street Group LLC now owns 145,969 shares of the company’s stock worth $406,000 after purchasing an additional 35,166 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of ASP Isotopes by 438.5% during the third quarter. Barclays PLC now owns 72,330 shares of the company’s stock worth $201,000 after buying an additional 58,897 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Stories

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.